All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
08Jan20 07:00 RNS Renalytix AI 0.00% Health £205.0m New commercial testing facility opens in Utah
03Jan20 07:00 RNS-R Renalytix AI 0.00% Health £205.0m CMS Pricing Determination becomes effective
03Dec19 07:00 RNS Renalytix AI 0.00% Health £205.0m Medicare sets US national price for KidneyIntelX
21Nov19 07:00 RNS Renalytix AI 0.00% Health £205.0m Grant of Options
19Nov19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m RenalytixAI attending City Event for Kidney Health
17Oct19 07:00 RNS Renalytix AI 0.00% Health £205.0m Partnership with CDPHP on KidneyIntelX
14Oct19 07:00 RNS Renalytix AI 0.00% Health £205.0m Board appointment
01Oct19 07:00 RNS Renalytix AI 0.00% Health £205.0m US CPT® reimbursement code effective
30Sep19 16:37 RNS Renalytix AI 0.00% Health £205.0m Result of AGM
30Sep19 08:00 RNS Renalytix AI 0.00% Health £205.0m Update on non-executive director appointment
30Sep19 07:00 RNS Renalytix AI 0.00% Health £205.0m Preliminary Medicare Pricing Determination
06Sep19 16:00 RNS Renalytix AI 0.00% Health £205.0m Posting of Annual Report & Accounts &Notice of AGM
03Sep19 07:00 RNS Renalytix AI 0.00% Health £205.0m Final Results
20Aug19 07:00 RNS Renalytix AI 0.00% Health £205.0m Notice of Results
06Aug19 07:00 RNS Renalytix AI 0.00% Health £205.0m Expansion of Chronic Kidney Disease Advisory Board
31Jul19 16:30 RNS Renalytix AI 0.00% Health £205.0m Total Voting Rights
29Jul19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m Thomas McLain Appointed as President and CCO
23Jul19 18:23 RNS Renalytix AI 0.00% Health £205.0m Result of Placing & Total Voting Rights
23Jul19 07:01 RNS Renalytix AI 0.00% Health £205.0m Proposed Placing to raise £12.0m (c.US$15.0m)
12Jul19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m US Exec Order on Advancing American Kidney Health
09Jul19 07:00 RNS Renalytix AI 0.00% Health £205.0m Positive Interim Results for Validation Study
08Jul19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m FractalDx Positive Results Published in JASN
01Jul19 07:00 RNS Renalytix AI 0.00% Health £205.0m US CPT® Code Granted for KidneyIntelX(TM)
07Jun19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m Positive results from FractalDx study published
04Jun19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m KidneyIntelX commercial scale production milestone
28May19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m CLIA Certificate Number issued for Renalytix Lab
21May19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m Expansion of FractalDx core investigator group
07May19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m University Medical Center Groningen collaboration
02May19 14:05 RNS Renalytix AI 0.00% Health £205.0m Second Price Monitoring Extn
02May19 14:00 RNS Renalytix AI 0.00% Health £205.0m Price Monitoring Extension
02May19 07:00 RNS Renalytix AI 0.00% Health £205.0m FDA grants Breakthrough Device designation
26Apr19 18:20 RNS EKF Diagnostics Holding -3.21% Various Various Acquisition of further interest in Renalytix AI
26Apr19 17:42 RNS Renalytix AI 0.00% Health £205.0m Director/PDMR Shareholding
02Apr19 12:55 RNS Renalytix AI 0.00% Health £205.0m Holding(s) in Company
01Apr19 07:00 RNS Renalytix AI 0.00% Health £205.0m Publication of confirmation study results
25Mar19 07:00 RNS Renalytix AI 0.00% Health £205.0m Half-year Report
22Mar19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m RenalytixAI Forms Core Investigator Group
12Mar19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m Investor briefing
14Feb19 07:00 RNS Renalytix AI 0.00% Health £205.0m Appointment of Nomad and Joint Broker
13Feb19 07:00 RNS Renalytix AI 0.00% Health £205.0m Joint venture partnership agreement with AKESOgen
06Feb19 07:00 RNS-R Renalytix AI 0.00% Health £205.0m RenalytixAI Expands Leadership Team
23Jan19 07:00 RNS Renalytix AI 0.00% Health £205.0m Initiates Clinical Validation Study
21Jan19 07:00 RNS EKF Diagnostics Holding -3.21% Various Various Clarification re. lock-up restrictions
02Jan19 07:00 RNS Renalytix AI 0.00% Health £205.0m Exercise of Option for Exclusive License
20Dec18 17:20 RNS Renalytix AI 0.00% Health £205.0m Director/PDMR Shareholding
20Dec18 07:01 RNS Renalytix AI 0.00% Health £205.0m Planned appointment of joint broker & of NOMAD
19Dec18 18:28 RNS Renalytix AI 0.00% Health £205.0m Director Dealing
17Dec18 13:30 RNS Renalytix AI 0.00% Health £205.0m Holding(s) in Company
Date / Time Source Company % Chg
08Jan20 07:00 RNS Renalytix AI 0.00%
New commercial testing facility opens in Utah
03Jan20 07:00 RNS-R Renalytix AI 0.00%
CMS Pricing Determination becomes effective
03Dec19 07:00 RNS Renalytix AI 0.00%
Medicare sets US national price for KidneyIntelX
21Nov19 07:00 RNS Renalytix AI 0.00%
Grant of Options
19Nov19 07:00 RNS-R Renalytix AI 0.00%
RenalytixAI attending City Event for Kidney Health
17Oct19 07:00 RNS Renalytix AI 0.00%
Partnership with CDPHP on KidneyIntelX
14Oct19 07:00 RNS Renalytix AI 0.00%
Board appointment
01Oct19 07:00 RNS Renalytix AI 0.00%
US CPT® reimbursement code effective
30Sep19 16:37 RNS Renalytix AI 0.00%
Result of AGM
30Sep19 08:00 RNS Renalytix AI 0.00%
Update on non-executive director appointment
30Sep19 07:00 RNS Renalytix AI 0.00%
Preliminary Medicare Pricing Determination
06Sep19 16:00 RNS Renalytix AI 0.00%
Posting of Annual Report & Accounts &Notice of AGM
03Sep19 07:00 RNS Renalytix AI 0.00%
Final Results
20Aug19 07:00 RNS Renalytix AI 0.00%
Notice of Results
06Aug19 07:00 RNS Renalytix AI 0.00%
Expansion of Chronic Kidney Disease Advisory Board
31Jul19 16:30 RNS Renalytix AI 0.00%
Total Voting Rights
29Jul19 07:00 RNS-R Renalytix AI 0.00%
Thomas McLain Appointed as President and CCO
23Jul19 18:23 RNS Renalytix AI 0.00%
Result of Placing & Total Voting Rights
23Jul19 07:01 RNS Renalytix AI 0.00%
Proposed Placing to raise £12.0m (c.US$15.0m)
12Jul19 07:00 RNS-R Renalytix AI 0.00%
US Exec Order on Advancing American Kidney Health
09Jul19 07:00 RNS Renalytix AI 0.00%
Positive Interim Results for Validation Study
08Jul19 07:00 RNS-R Renalytix AI 0.00%
FractalDx Positive Results Published in JASN
01Jul19 07:00 RNS Renalytix AI 0.00%
US CPT® Code Granted for KidneyIntelX(TM)
07Jun19 07:00 RNS-R Renalytix AI 0.00%
Positive results from FractalDx study published
04Jun19 07:00 RNS-R Renalytix AI 0.00%
KidneyIntelX commercial scale production milestone
28May19 07:00 RNS-R Renalytix AI 0.00%
CLIA Certificate Number issued for Renalytix Lab
21May19 07:00 RNS-R Renalytix AI 0.00%
Expansion of FractalDx core investigator group
07May19 07:00 RNS-R Renalytix AI 0.00%
University Medical Center Groningen collaboration
02May19 14:05 RNS Renalytix AI 0.00%
Second Price Monitoring Extn
02May19 14:00 RNS Renalytix AI 0.00%
Price Monitoring Extension
02May19 07:00 RNS Renalytix AI 0.00%
FDA grants Breakthrough Device designation
26Apr19 18:20 RNS EKF Diagnostics Holding -3.21%
Acquisition of further interest in Renalytix AI
26Apr19 17:42 RNS Renalytix AI 0.00%
Director/PDMR Shareholding
02Apr19 12:55 RNS Renalytix AI 0.00%
Holding(s) in Company
01Apr19 07:00 RNS Renalytix AI 0.00%
Publication of confirmation study results
25Mar19 07:00 RNS Renalytix AI 0.00%
Half-year Report
22Mar19 07:00 RNS-R Renalytix AI 0.00%
RenalytixAI Forms Core Investigator Group
12Mar19 07:00 RNS-R Renalytix AI 0.00%
Investor briefing
14Feb19 07:00 RNS Renalytix AI 0.00%
Appointment of Nomad and Joint Broker
13Feb19 07:00 RNS Renalytix AI 0.00%
Joint venture partnership agreement with AKESOgen
06Feb19 07:00 RNS-R Renalytix AI 0.00%
RenalytixAI Expands Leadership Team
23Jan19 07:00 RNS Renalytix AI 0.00%
Initiates Clinical Validation Study
21Jan19 07:00 RNS EKF Diagnostics Holding -3.21%
Clarification re. lock-up restrictions
02Jan19 07:00 RNS Renalytix AI 0.00%
Exercise of Option for Exclusive License
20Dec18 17:20 RNS Renalytix AI 0.00%
Director/PDMR Shareholding
20Dec18 07:01 RNS Renalytix AI 0.00%
Planned appointment of joint broker & of NOMAD
19Dec18 18:28 RNS Renalytix AI 0.00%
Director Dealing
17Dec18 13:30 RNS Renalytix AI 0.00%
Holding(s) in Company
Date / Time Company % Chg
08Jan20 07:00 Renalytix AI 0.00%
New commercial testing facility opens in Utah
03Jan20 07:00 Renalytix AI 0.00%
CMS Pricing Determination becomes effective
03Dec19 07:00 Renalytix AI 0.00%
Medicare sets US national price for KidneyIntelX
21Nov19 07:00 Renalytix AI 0.00%
Grant of Options
19Nov19 07:00 Renalytix AI 0.00%
RenalytixAI attending City Event for Kidney Health
17Oct19 07:00 Renalytix AI 0.00%
Partnership with CDPHP on KidneyIntelX
14Oct19 07:00 Renalytix AI 0.00%
Board appointment
01Oct19 07:00 Renalytix AI 0.00%
US CPT® reimbursement code effective
30Sep19 16:37 Renalytix AI 0.00%
Result of AGM
30Sep19 08:00 Renalytix AI 0.00%
Update on non-executive director appointment
30Sep19 07:00 Renalytix AI 0.00%
Preliminary Medicare Pricing Determination
06Sep19 16:00 Renalytix AI 0.00%
Posting of Annual Report & Accounts &Notice of AGM
03Sep19 07:00 Renalytix AI 0.00%
Final Results
20Aug19 07:00 Renalytix AI 0.00%
Notice of Results
06Aug19 07:00 Renalytix AI 0.00%
Expansion of Chronic Kidney Disease Advisory Board
31Jul19 16:30 Renalytix AI 0.00%
Total Voting Rights
29Jul19 07:00 Renalytix AI 0.00%
Thomas McLain Appointed as President and CCO
23Jul19 18:23 Renalytix AI 0.00%
Result of Placing & Total Voting Rights
23Jul19 07:01 Renalytix AI 0.00%
Proposed Placing to raise £12.0m (c.US$15.0m)
12Jul19 07:00 Renalytix AI 0.00%
US Exec Order on Advancing American Kidney Health
09Jul19 07:00 Renalytix AI 0.00%
Positive Interim Results for Validation Study
08Jul19 07:00 Renalytix AI 0.00%
FractalDx Positive Results Published in JASN
01Jul19 07:00 Renalytix AI 0.00%
US CPT® Code Granted for KidneyIntelX(TM)
07Jun19 07:00 Renalytix AI 0.00%
Positive results from FractalDx study published
04Jun19 07:00 Renalytix AI 0.00%
KidneyIntelX commercial scale production milestone
28May19 07:00 Renalytix AI 0.00%
CLIA Certificate Number issued for Renalytix Lab
21May19 07:00 Renalytix AI 0.00%
Expansion of FractalDx core investigator group
07May19 07:00 Renalytix AI 0.00%
University Medical Center Groningen collaboration
02May19 14:05 Renalytix AI 0.00%
Second Price Monitoring Extn
02May19 14:00 Renalytix AI 0.00%
Price Monitoring Extension
02May19 07:00 Renalytix AI 0.00%
FDA grants Breakthrough Device designation
26Apr19 18:20 EKF LSE,RENX LSE -3.21%
Acquisition of further interest in Renalytix AI
26Apr19 17:42 Renalytix AI 0.00%
Director/PDMR Shareholding
02Apr19 12:55 Renalytix AI 0.00%
Holding(s) in Company
01Apr19 07:00 Renalytix AI 0.00%
Publication of confirmation study results
25Mar19 07:00 Renalytix AI 0.00%
Half-year Report
22Mar19 07:00 Renalytix AI 0.00%
RenalytixAI Forms Core Investigator Group
12Mar19 07:00 Renalytix AI 0.00%
Investor briefing
14Feb19 07:00 Renalytix AI 0.00%
Appointment of Nomad and Joint Broker
13Feb19 07:00 Renalytix AI 0.00%
Joint venture partnership agreement with AKESOgen
06Feb19 07:00 Renalytix AI 0.00%
RenalytixAI Expands Leadership Team
23Jan19 07:00 Renalytix AI 0.00%
Initiates Clinical Validation Study
21Jan19 07:00 EKF LSE,RENX LSE -3.21%
Clarification re. lock-up restrictions
02Jan19 07:00 Renalytix AI 0.00%
Exercise of Option for Exclusive License
20Dec18 17:20 Renalytix AI 0.00%
Director/PDMR Shareholding
20Dec18 07:01 Renalytix AI 0.00%
Planned appointment of joint broker & of NOMAD
19Dec18 18:28 Renalytix AI 0.00%
Director Dealing
17Dec18 13:30 Renalytix AI 0.00%
Holding(s) in Company